Dokumendiregister | Ravimiamet |
Viit | MSO-13/808-2 |
Registreeritud | 18.02.2025 |
Sünkroonitud | 19.02.2025 |
Liik | Väljaminev kiri |
Funktsioon | MSO Meditsiiniseadmed |
Sari | MSO-13 Meditsiiniseadmete kliiniliste uuringute ja toimivusuuringute dokumendid (taotlused, load, muud teavitused ja kirjavahetus) |
Toimik | MSO-13/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | IQVIA MedTech |
Saabumis/saatmisviis | IQVIA MedTech |
Vastutaja | Merili Saar-Abroi (RA, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: RA MSO <[email protected]>
Sent: Mon, 13 Jan 2025 12:09:42 +0000
To: "Podolak; Amira" <[email protected]>
Cc: RA MSO <[email protected]>
Subject: Vs: Publication of data
Dear Dr. Podolak
State Agency of Medicines does not publish any data regarding medical devices studies submitted for their authorisation.
All the best,
Merili Saar-Abroi on behalf of
Department of Medical Devices
State Agency of Medicines
1 Nooruse Street
50411 Tartu
Estonia
Phone: +372 737 4140
www.ravimiamet.ee
Saatja: Podolak, Amira <[email protected]>
Saatmisaeg: neljapäev, 9. jaanuar 2025 12:24
Adressaat: RA MSO <[email protected]>
Teema: Publication of data
Dear Sirs,
I’d like to confirm if the State Agency of Medicines publish any data regarding medical devices studies submitted for their authorization? I’d highly appreciate your feedback regarding this matter.
Kind regards,
Amira Podolak, Ph.D.
Associate Regulatory & Start-Up Manager
IQVIA MedTech, Clinical Operations
Learn more about IQVIA MedTech
Home Based (Gdynia, Poland)
tel. +48 22 430 31 34
Upcoming ooo: 17Feb-28Feb (holidays)
________________________________________
IMPORTANT - PLEASE READ: This electronic message, including its attachments, is CONFIDENTIAL and may contain PROPRIETARY or LEGALLY PRIVILEGED or PROTECTED information and is intended for the authorized recipient of the sender. If you are not the intended recipient, you are hereby notified that any use, disclosure, copying, or distribution of this message or any of the information included in it is unauthorized and strictly prohibited. If you have received this message in error, please immediately notify the sender by reply e-mail and permanently delete this message and its attachments, along with any copies thereof, from all locations received (e.g., computer, mobile device, etc.). To the extent permitted by law, we may monitor electronic communications for the purposes of ensuring compliance with our legal and regulatory obligations and internal policies. We may also collect email traffic headers for analyzing patterns of network traffic and managing client relationships. For further information see our privacy-policy. Thank you.
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Küsimused | 18.02.2025 | 1 | MSO-13/808-1 | Sissetulev kiri | ra | IQVIA MedTech |